Valuation: DreamCIS, Inc.

Market Cap 87.95B 62.26M 53.95M 50.51M 46.09M 86.73M 5.94B 88.18M 592M 232M 2.97B 234M 229M 9.92B P/E 2026 *
8.96x
P/E 2027 * 6.66x
Enterprise Value 44.95M 31.82K 27.57K 25.81K 23.55K 44.32K 3.03M 45.07K 303K 119K 1.52M 119K 117K 5.07M EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.32x
Free-Float
30.37%
Yield 2026 *
-
Yield 2027 * -
03-22 DreamCIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-01 Curi Bio, Inc. announced that it has received $10 million in funding from DreamCIS, Inc. CI
11-10 DreamCIS, Inc. agreed to acquire 13.01% stake in Curi Bio, Inc. CI
11-10 Curi Bio, Inc. announced that it expects to receive $14.848537 million in funding from DreamCIS, Inc. CI
25-09-29 DreamCIS, Inc. announced that it has received KRW 15 billion in funding from Hong Kong Tigermed Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd. CI
25-09-21 DreamCIS, Inc. announced that it expects to receive KRW 15 billion in funding from Hong Kong Tigermed Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and other investors CI
24-02-22 Curi Bio, Genetox and DreamCIS Sign MOU for Strategic Collaboration on 3D Neuromuscular Junction Model for Botox Potency Assay CI
23-12-21 T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
23-12-13 T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc. CI
23-03-21 DreamCIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-03-27 DreamCIS, Inc. announced that it has received KRW 2.9999925 billion in funding CI
22-03-16 DreamCIS, Inc. announced that it expects to receive KRW 2.9999925 billion in funding CI
20-05-21 DreamCIS, Inc. has completed an IPO in the amount of KRW 20.186311 billion. CI
1 day+2.88%
1 week+9.66%
Current month+26.33%
1 month+10.51%
3 months-49.86%
6 months-41.49%
Current year-43.97%
1 week 3,185
Extreme 3185
3,640
1 month 2,360
Extreme 2360
3,640
Current year 2,360
Extreme 2360
8,640
1 year 2,360
Extreme 2360
8,640
3 years 2,360
Extreme 2360
9,750
5 years 2,360
Extreme 2360
9,750
10 years 2,360
Extreme 2360
9,750
Manager TitleAgeSince
Chief Executive Officer 56 2022-03-29
Director of Finance/CFO 57 2016-04-30
Director TitleAgeSince
Director/Board Member 57 2016-04-30
Director/Board Member 53 2019-08-29
Director/Board Member 45 2019-08-29
Date Insider Type Main position Quantity % Market Cap.
12/16/24 Buy

Chief Executive Officer

30,000 0.1261%
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%+9.66%+0.56%+0.07% 60.29M
-1.77%+13.64%+99.13%+456.34% 45.89B
+0.35%+3.23%+20.45%+47.90% 26.06B
-0.55%+0.92%-19.75%-33.58% 7.82B
-1.22%+10.29%+23.13%+142.43% 6.08B
-0.21%+2.60%+22.24%+65.21% 3.42B
+4.96%+15.29%-26.05%+1,451.04% 2.32B
-0.60%+1.47%+184.02%+17.57% 2.14B
+1.65%+13.78%+2.48%-50.23% 2.13B
+9.55%+6.29%+30.18%+21.90% 2.01B
Average +1.49%+276.06%+33.64%+211.86% 9.79B
Weighted average by Cap. -0.53%+300.78%+56.61%+269.21%

Financials

2026 *2027 *
Net sales 90B 63.71M 55.21M 51.69M 47.16M 88.75M 6.08B 90.24M 606M 237M 3.04B 239M 234M 10.15B 117B 82.72M 71.68M 67.11M 61.23M 115M 7.89B 117M 787M 308M 3.95B 311M 304M 13.17B
Net income 9.8B 6.94M 6.01M 5.63M 5.14M 9.66M 662M 9.83M 65.99M 25.86M 331M 26.05M 25.48M 1.1B 13.2B 9.34M 8.1M 7.58M 6.92M 13.02M 891M 13.24M 88.89M 34.83M 446M 35.09M 34.32M 1.49B
Net Debt -43B -30.44M -26.38M -24.7M -22.53M -42.4M -2.9B -43.12M -290M -113M -1.45B -114M -112M -4.85B -51B -36.1M -31.29M -29.29M -26.73M -50.29M -3.44B -51.14M -343M -135M -1.72B -136M -133M -5.75B
Logo DreamCIS, Inc.
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
Employees
391
Date Price Change Volume
26-08-11 ₩3,575.00 +2.88% 59,849
26-08-10 ₩3,475.00 +2.51% 130,367
26-08-07 ₩3,390.00 +3.83% 89,474
26-08-06 ₩3,265.00 +0.15% 51,315
26-08-05 ₩3,260.00 0.00% 53,047
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A223250 Stock